TITLE

Choroidal neovascularization after blunt ocular trauma in angioid streaks

AUTHOR(S)

Kubota, Masaomi; Hayashi, Takaaki; Arai, Kota; Tsuneoka, Hiroshi

PUB. DATE

July 2013

SOURCE

Clinical Ophthalmology;2013, Vol. 7, p1347

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Background: Patients with angioid streaks are prone to develop a subretinal hemorrhage after ocular injury, due to fragility of Bruch's membrane. Objective: The purpose of this study was to report a patient with angioid streaks in whom subfoveal choroidal neovascularization (CNV) developed after blunt ocular trauma. Case report: A 60-year-old man was accidentally struck in the left eye with a crowbar handle while engaged in the demolition of wooden building materials in May 2011 and was initially evaluated at our hospital. Corrected visual acuity was 0.3 in the right and 1.2 in the left eye, and relative afferent pupillary defect was negative. Funduscopy revealed choroidal atrophy around the optic papillae and angioid streaks radiating from around the optic discs in both eyes. In the right eye, there was macular atrophy. In the left eye, there was a subretinal hemorrhage around the macular region. Fluorescein angiography of the left eye showed a blockage due to subretinal hemorrhage and increasing hyperfluorescent spots superior to the fovea, suggestive of extrafoveal CNV. Spectral-domain optical coherence tomography showed macular thinning in the right eye and no obvious abnormalities near the subfoveal region in the left eye. Two months later, the patient noticed decreased visual acuity in the left eye and was reevaluated. Visual acuity had decreased to 0.7, and well-defined CNV, one disc diameter in size, was presenting slightly superior to the macula, including the subfoveal region. Two weeks later, anti-vascular endothelial growth factor (anti-VEGF) antibody (bevacizumab) was injected intravitreally; the CNV then regressed, and visual acuity improved to 1.2. Conclusion: Marked improvement in visual acuity with early treatment has not been reported in angioid streaks with subfoveal CNV after ocular injury. Intravitreal injection of an anti-VEGF antibody should be considered early after the diagnosis of CNV.

ACCESSION #

89892982

 

Related Articles

• Intravitreal ranibizumab for choroidal neovascularization secondary to angiod streaks. Comparison of the 12 and 24-month results of treatment in treatment-naïve eyes. LADAS, D. S.; KOUTSANDREA, C.; KOTSOLIS, A. I.; GEORGALAS, I.; MOSCHOS, M. M.; LADAS, I. D. // European Review for Medical & Pharmacological Sciences;Jul2016, Vol. 20 Issue 13, p2779 

  OBJECTIVE: Our aim study was to compare 12 and 24-month results of intravitreal ranibizumab therapy in the management of choroidal neovascularization (CNV) secondary to angioid streaks (ST). This could be of clinical importance helping us planning optimal dosing strategies. PATIENTS AND METHODS:...

• Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration. Jain, Sachin; Kishore, Kamal; Sharma, Yog Raj // Indian Journal of Ophthalmology;Sep2013, Vol. 61 Issue 9, p490 

  Aim: To investigate the role of anti-VEGF monotherapy in patients with thick submacular hemorrhage (SMH) of =1 week duration secondary to neovascular age-related macular degeneration (N-AMD). Materials and Methods: A retrospective chart review of 14 eyes of 14 patients presenting with acute...

• Enhanced depth imaging of the choroid in patients with neovascular age-related macular degeneration treated with anti-VEGF therapy versus untreated patients. Rahman, Waheeda; Chen, Fred; Yeoh, Jonathan; Cruz, Lyndon // Graefe's Archive of Clinical & Experimental Ophthalmology;Jun2013, Vol. 251 Issue 6, p1483 

  Purpose: To compare the subfoveal choroidal thickness (SFCT) between patients with neovascular age-related macular degeneration (nAMD) who had multiple intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents and those with treatment-naïve nAMD. Methods: This...

• What are the real-world therapeutic strategies for treating DME in practice today? Eichenbaum, David A.; Kiss, Szilárd // Ocular Surgery News;4/25/2015, Vol. 33 Issue 8, p11 

  The article presents the contrasting views of ophthalmologists David A. Eichenbaum and Szilárd Kiss on the real-word therapeutic strategies for treating diabetic macular edema (DME) in practice today. Eichenbaum highlights the benefits of start with an anti-vascular endothelial growth factor...

• Tomographic fundus features in pseudoxanthoma elasticum: comparison with neovascular age-related macular degeneration in Japanese patients. Ellabban, A A; Hangai, M; Yamashiro, K; Nakagawa, S; Tsujikawa, A; Yoshimura, N // Eye;Aug2012, Vol. 26 Issue 8, p1086 

  PurposeTo determine the retinal and subretinal features characteristic to pseudoxanthoma elasticum (PXE) compared with age-related macular degeneration by using spectral-domain optical coherence tomography (SD-OCT) in Japanese patients.MethodsWe reviewed colour fundus photographs, fluorescein...

• Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy. Figueroa, Marta S.; Contreras, Inés; Noval, Susana // Current Diabetes Reviews;2009, Vol. 5 Issue 1, p52 

  Anti-VEGF drugs may be employed in the surgical treatment of diabetic retinopathy: 1. Prior to surgery. The intravitreal injection of anti-VEGF drugs leads to a significant reduction of neovascularization, with a reduction in the adherence of the fibrovascular complex to the retina. This...

• Breakthrough studies revive discussion of anti-VEGF treatment regimens for AMD.  // Ocular Surgery News Europe;Feb2012, Vol. 23 Issue 2, p1 

  The article tackles the retrospective observational study LUMIERE which examined the current practices of ranibizumab treatment in France which were presented at the 2011 Association for Research in Vision and Ophthalmology meeting. The study has reportedly revived discussion of anti-vascular...

• Identification of ORT after anti-VEGF treatment for neovascular AMD critical.  // Ocular Surgery News;11/25/2014, Vol. 32 Issue 22, p34 

  The article reports on a study published in the journal "Ophthalmology" that reveals the importance of identification of eyes with outer retinal tubulations after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.

• Intravitreal ranibizumab for the treatment of choroidal neovascularisation secondary to angioid streaks. Shah, M; Amoaku, W M K // Eye;Sep2012, Vol. 26 Issue 9, p1194 

  AimsTo assess the medium to long-term efficacy and safety of intravitreal ranibizumab for the treatment of choroidal neovascularisation (CNV) secondary to angioid streaks (AS).MethodsA total of 12 eyes of nine patients treated with intravitreal ranibizumab (0.5 mg in 0.05 ml) for CNV secondary...

Read the Article